Abingdon Health Plc (AIM:ABDX)
London · Delayed Price · Currency is GBP · Price in GBX 7.10
-0.15 (-2.07%)
Mar 26, 2026, 3:48 PM GMT
Abingdon Health Revenue
Abingdon Health had revenue of 4.24M GBP in the half year ending December 31, 2025, with 75.81% growth. This brings the company's revenue in the last twelve months to 9.57M, up 40.37% year-over-year. In the fiscal year ending June 30, 2025, Abingdon Health had annual revenue of 8.43M with 37.39% growth.
Revenue (ttm)
9.57M
Revenue Growth
+40.37%
P/S Ratio
3.28
Revenue / Employee
74.20K
Employees
124
Market Cap
31.42M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 8.43M | 2.29M | 37.39% |
| Jun 30, 2024 | 6.14M | 2.09M | 51.67% |
| Jun 30, 2023 | 4.05M | 1.21M | 42.68% |
| Jun 30, 2022 | 2.84M | -8.78M | -75.60% |
| Jun 30, 2021 | 11.62M | 6.38M | 121.93% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.64B |
| GSK plc | 32.67B |
| Haleon | 11.03B |
| Smith & Nephew | 4.58B |
| Kooth | 66.34M |
| AOTI, Inc. | 46.61M |
| Palatin Technologies | 6.66M |
| Arecor Therapeutics | 5.06M |
Abingdon Health News
- 1 year ago - UK Stock Market News: Abingdon Health, Wood Group, Team Internet - The Armchair Trader
- 1 year ago - AIM Market Roundup: Good Energy, Beacon Energy, Abingdon Health - The Armchair Trader
- 1 year ago - Small Cap Stocks: Hummingbird, LPA Group, Cadence Minerals - The Armchair Trader